butabarbital decreases effects of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Closely. Coadministration of CYP3A4 inducers could reduce sufentanil amounts and efficacy, perhaps precipitating withdrawal syndrome in sufferers who may have designed Bodily dependence to sufentanil. Discontinuation of c